GSK Recalling Three Batches of Children’s Panadol Due to Potential Contamination
The Therapeutic Goods Administration has just confirmed that GlaxoSmithKline is in the process of recalling three batches of Children’s Panadol 5-12 years suspension supplied in 200mL bottles.
According to the update “it has been identified that an ingredient used in the manufacture of these medicines may have been contaminated with small particles that could contain trace minerals and inert fibres”.
The quantities of the particles would be small and may not be visible, with the TGA advising that if this occurs there is a very low risk of allergic reaction and there is also potential for the medicine to be less effective over time.
The affected batch numbers are 136418 (strawberry flavour), 136444 (strawberry flavour) and 136443 (orange flavour), all with an expiry date of February 2018.
No other batches, bottle sizes or products are affected by the recall. Pharmacies with affected product are advised to quarantine it and arrange for its return in accordance with recall procedures advised by GSK.